Skip to main content

Table 3 Comparison between groups I and II according to HCC recurrence

From: Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma recurrence

 Group I (n = 50), no. (%)Group II (n = 50), no. (%)χ2p
HCC recurrence19 (38%)31 (62%)5.760*0.016*
  1. *Statistically significant at p ≤ 0.05